A new class of experimental drug - like small molecules is showing great promise in targeting a brain enzyme to
prevent early memory loss in Alzheimer's disease, according to Northwestern Medicine ® research.
Not exact matches
«Now that we have more evidence that serotonin is a chemical that appears affected
early in cognitive decline, we suspect that increasing serotonin function in the brain could
prevent memory loss from getting worse and slow disease progression,» says Gwenn Smith, Ph.D., professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine and director of geriatric psychiatry and neuropsychiatry at Johns Hopkins University School of Medicine.
«Our findings highlight the potential value of programs that promote developing working
memory early as a way to
prevent disparities in achievement,» Hackman continues.
Injections of a natural growth factor into the brains of mice, rats and monkeys offers hope of
preventing or reversing the
earliest impacts of Alzheimer's disease on
memory.
They found that
early - life stress reduces the levels of these nutrients in mouse pups, but supplementation
prevented the reduction of methionine levels and even
prevented some of the lasting negative effects of
early - life stress on later learning and
memory in adult offspring.
Shetty's
earlier research has shown that this compound may be able to help
prevent memory loss occurring with aging.